Physician

Abhitabh Patil, M.D.

According to 2025 Medicare claims, Abhitabh Patil, M.D. (NPI: 1346371085) practices gastroenterology in the St. Petersburg-Clearwater-Largo, FL market, with the plurality of this provider's patient population coming from Pinellas, FL. This provider's primary affiliated billing organization is BAYCARE MEDICAL GROUP, INC. (NPI: 1043269871; TIN: 593140335) and primary practice location at 33705-1300. Patil is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604) and Pearl Network, LLC (ACO ID: D0243), participating under both the MSSP and REACH models.

Patil's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 413 traditional Medicare patients, billed 817 HCPCS/CPT codes, and received $93,105 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 835 prescription claims across 443 beneficiaries totaling $541,845 in drug costs, led by Creon (Lipase/Protease/Amylase). Open Payments data shows 69 records totaling $49,633. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $151,851 to $93,105. Similarly, Part D prescription costs have moved from a higher plateau to a lower plateau, from $1,389,703 to $541,845. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	536	1,272	$151,851
2016	546	1,328	$156,437
2017	502	1,144	$133,123
2018	519	1,180	$146,315
2019	533	1,196	$144,890
2020	502	1,068	$125,292
2021	650	1,328	$173,879
2022	534	1,111	$131,652
2023	450	1,082	$122,509
2024	413	817	$93,105

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	465	932	$1,389,703
2016	501	1,031	$1,899,627
2017	473	998	$753,986
2018	500	1,065	$785,418
2019	452	946	$517,791
2020	406	923	$996,275
2021	684	1,411	$1,370,894
2022	678	1,501	$842,302
2023	571	1,146	$677,794
2024	443	835	$541,845

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	46	46	$186
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	82	82	$120
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	113	137	$87
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	72	72	$87
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	60	62	$65

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Creon	Lipase/Protease/Amylase	27	1,481	$174,745
Xifaxan	Rifaximin	17	494	$55,820
Clenpiq	Sod Picosulf/Mag Ox/Citric Ac	100	180	$17,156
Suflave	Peg 3350/Sod Sulf,chlr/Pot/Mag	52	212	$6,548
Amitriptyline Hcl	Amitriptyline Hcl	180	13,809	$3,673

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	69	$49,633	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abhitabh Patil, M.D.?

Tedicare shows public-source Medicare data for Abhitabh Patil, M.D. (NPI 1346371085), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abhitabh Patil, M.D. have ACO affiliation data?

Abhitabh Patil, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604) and Pearl Network, LLC (REACH, ACO ID D0243).

What billing organization is linked to Abhitabh Patil, M.D.?

Abhitabh Patil, M.D. is linked to BAYCARE MEDICAL GROUP, INC. (billing NPI 1043269871) in the available physician profile data.

Does Abhitabh Patil, M.D. have Open Payments data?

Abhitabh Patil, M.D. has 69 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.